A study presented at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% ...

A point-of-care lung ultrasound system connected to a smartphone combined with a suite of deep learning models outperformed ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

A pioneering study presented today at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing pulmonary tuberculosis (TB).

A study has shown that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing pulmonary tuberculosis ...

Kazemzadeh and colleagues evaluated the performance of AI systems that detect TB and chest X-ray abnormalities against that of radiologists. 2. AI demonstrated non-inferiority to the radiologists for ...

In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...

A pioneering study presented today at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing pulmonary tuberculosis (TB).1 ...

Findings from the study, published in Nature Communications, could lead to more effective and less onerous therapies that reduce lung damage in TB survivors. It could also prevent lung dysfunction ...